Public Consultation on Comprehensive Cost-Benefit Assessment on the Medicine Pricing Policy (Preliminary Findings)

Date: 30 November 2021 - 12:22pm
News categories: 
Announcement
Released date: 
Tuesday, 30 November 2021

Title: Public Consultation on Comprehensive Cost-Benefit Assessment on the Medicine Pricing Policy (Preliminary Findings)
Date: 29/11/2021 - 06/12/2021
Location: Portal UPC
https://upc.mpc.gov.my/csp/sys/bi/%25cspapp.bi.work.nc.custom.regulation...

Malaysia Productivity Corporation (MPC) is currently conducting Public Consultation on Comprehensive Cost-Benefit Assessment on the Medicine Pricing Policy (Preliminary Findings). The purpose of this consultation is to seek the feedback of interested parties on the report, particularly the preliminary findings of the cost-benefit assessment on the proposed medicine pricing policy before the consultant finalizes their analysis.

All stakeholders are invited to submit comments and join the survey through the attached link.  

By, 
Medicines Price Management Branch. 
Pharmacy Practice and Development Division
 

  • 548 reads